Associated Papers
BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage.
Wang W et al.
Bmc Neurology, 2021
33980169 (PubMed )
Supplement: 12883_2021_2224_MOESM1_ESM.xlsx › Sheet1
CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.
Tovar-Parra JD et al.
Biomed Research International, 2020
BRAF AMP Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAF V600E.
Da R et al.
Frontiers in Oncology, 2020
33489866 (PubMed )
Supplement: Table_1.xlsx › Sheet1
Familial cutaneous melanoma.
Hansson J
Advances in Experimental Medicine and Biology, 2010
High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC et al.
Expert Review of Anticancer Therapy, 2006
Select a paper to view details